123 related articles for article (PubMed ID: 36866985)
1. What has changed in the last 25 years in osteosarcoma treatment? A single center experience.
Ataseven E; Göktepe ŞÖ; Kaya H; Tamsel İ; Keçeci B; Argın M; Doğanavşargil B; Sabah D; Burak Z; Kantar M
Turk J Pediatr; 2023; 65(1):54-63. PubMed ID: 36866985
[TBL] [Abstract][Full Text] [Related]
2. Phase 2 study for nonmetastatic extremity high-grade osteosarcoma in pediatric and adolescent and young adult patients with a risk-adapted strategy based on ABCB1/P-glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS-2).
Palmerini E; Meazza C; Tamburini A; Bisogno G; Ferraresi V; Asaftei SD; Milano GM; Coccoli L; Manzitti C; Luksch R; Serra M; Gambarotti M; Donati DM; Scotlandi K; Bertulli R; Favre C; Longhi A; Abate ME; Perrotta S; Mascarin M; D'Angelo P; Cesari M; Staals EL; Marchesi E; Carretta E; Ibrahim T; Casali PG; Picci P; Fagioli F; Ferrari S
Cancer; 2022 May; 128(10):1958-1966. PubMed ID: 35201621
[TBL] [Abstract][Full Text] [Related]
3. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
Kokkali S; Kotsantis I; Magou E; Sophia T; Kormas T; Diakoumis G; Spathas N; Psyrri A; Ardavanis A
Invest New Drugs; 2022 Jun; 40(3):668-675. PubMed ID: 35312944
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prognostic factors and histopathological response to neoadjuvant chemotherapy in osteosarcoma.
Erdoğan F; Çinka H; Akman BÇ; Coşkun HS; Dabak N
Jt Dis Relat Surg; 2023; 34(1):196-206. PubMed ID: 36700283
[TBL] [Abstract][Full Text] [Related]
5. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
7. Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience.
Taçyıldız N; Unal E; Dinçaslan H; Çakmak HM; Köse K; Tanyıldız G; Kartal Ö
Asian Pac J Cancer Prev; 2020 Mar; 21(3):715-720. PubMed ID: 32212798
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
[TBL] [Abstract][Full Text] [Related]
9. [Results of the treatment of pediatric osteosarcoma in the Hungarian population].
Hegyi M; Félné Semsei A; Jakab Z; Antal I; Kiss J; Szendrõi M; Csóka M; Kovács G
Magy Onkol; 2012 Mar; 56(1):30-7. PubMed ID: 22403760
[TBL] [Abstract][Full Text] [Related]
10. Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.
Anderson PM; Meyers P; Kleinerman E; Venkatakrishnan K; Hughes DP; Herzog C; Huh W; Sutphin R; Vyas YM; Shen V; Warwick A; Yeager N; Oliva C; Wang B; Liu Y; Chou A
Pediatr Blood Cancer; 2014 Feb; 61(2):238-44. PubMed ID: 23997016
[TBL] [Abstract][Full Text] [Related]
11. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
[TBL] [Abstract][Full Text] [Related]
13. IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival.
Verma P; Jain S; Kapoor G; Tripathi R; Sharma P; Doval DC
J Pediatr Hematol Oncol; 2021 May; 43(4):e466-e471. PubMed ID: 32925402
[TBL] [Abstract][Full Text] [Related]
14. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.
Bacci G; Briccoli A; Ferrari S; Longhi A; Mercuri M; Capanna R; Donati D; Lari S; Forni C; DePaolis M
Eur J Cancer; 2001 Nov; 37(16):2030-9. PubMed ID: 11597381
[TBL] [Abstract][Full Text] [Related]
16. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.
Scully SP; Ghert MA; Zurakowski D; Thompson RC; Gebhardt MC
J Bone Joint Surg Am; 2002 Jan; 84(1):49-57. PubMed ID: 11792779
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy.
Bacci G; Longhi A; Fagioli F; Briccoli A; Versari M; Picci P
Eur J Cancer; 2005 Dec; 41(18):2836-45. PubMed ID: 16298125
[TBL] [Abstract][Full Text] [Related]
18. Impacts of Tumor Location, Nature and Bone Destruction of Extremity Osteosarcoma on Selection of Limb Salvage Operative Procedure.
Chen Y; Yu XC; Xu SF; Xu M; Song RX
Orthop Surg; 2016 May; 8(2):139-49. PubMed ID: 27384722
[TBL] [Abstract][Full Text] [Related]
19. Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Nataraj V; Batra A; Rastogi S; Khan SA; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 Nov; 112(6):662-8. PubMed ID: 26381138
[TBL] [Abstract][Full Text] [Related]
20. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy.
Hegyi M; Semsei AF; Jakab Z; Antal I; Kiss J; Szendroi M; Csoka M; Kovacs G
Pediatr Blood Cancer; 2011 Sep; 57(3):415-22. PubMed ID: 21563300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
